KALA BIO, Inc. filed a Form D with the Securities and Exchange Commission on 2026-03-17.
KALA BIO, Inc. filed a Form D notice of an exempt securities offering with the SEC on March 17, 2026. The filing reports $1.75M sold. Its industry group is Pharmaceuticals. It names Avi Minkowitz (Executive Officer, Director), Hillel Posen (Director), Chaim Berger (Director) (SEC Form D, March 17, 2026).
Sell to companies like KALA BIO, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-03-17 · the record
Pitching, partnering or investing alongside them? See who really runs and owns KALA BIO, Inc.
Free to see. No signup.
More on the people and the money behind KALA BIO, Inc., from the filings we hold.
Pharmaceuticals raises by companies based in Massachusetts, filed in March 2026, largest first.
Get an email when KALA BIO, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when KALA BIO, Inc. raises, hires or launches. No email unless you switch it on.
Watch KALA BIO, Inc. →Get the full cited report on KALA BIO, Inc.
What the filing shows about KALA BIO, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on KALA BIO, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for KALA BIO, Inc. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 157 filings in Pharmaceuticals, totalled by week. The dot is this raise, $1.75M, on the same scale — one filing against the whole group's total, so it sits low by construction.
Avi Minkowitz is named as Executive Officer and Director on the Form D that KALA BIO, Inc. filed with the SEC on 17 March 2026, one of 5 people that filing names.
Hillel Posen is named as Director on the Form D that KALA BIO, Inc. filed with the SEC on 17 March 2026, one of 5 people that filing names.
Chaim Berger is named as Director on the Form D that KALA BIO, Inc. filed with the SEC on 17 March 2026, one of 5 people that filing names.
Yonatan Colman is named as Director on the Form D that KALA BIO, Inc. filed with the SEC on 17 March 2026, one of 5 people that filing names.
Brendan Purdy is named as Director on the Form D that KALA BIO, Inc. filed with the SEC on 17 March 2026, one of 5 people that filing names.
5 people named on the filing — 1 holding an executive role and 4 as directors only.
Named as of the 2026-03-17 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about KALA BIO, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on KALA BIO, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on KALA BIO, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist KALA BIO, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind KALA BIO, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for KALA BIO, Inc.. With no account yet, you sign up free and land on the result.
https://mentionfox.com/funding/kala-bio-inc-form-d-26000002